Escherichia coli Lipopolysaccharide (LPS) Antibody (Biotin)

Product specifications

Primary Antibodies

Escherichia coli Lipopolysaccharide (LPS)

Rabbit

General

IHC (Predicted): 5-20 µg/ml, IF/ICC (Predicted): 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user.

Polyclonal

Biotin

IgG

Purified by antigen-specific affinity chromatography.

200 µl

1 ml

Liquid

ELISA

0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.

Shipped within 5-15 working days.

Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. Avoid repeated freeze/thaw cycles.

No

LPS

Antibody anti-LPS

RUO

Descripción

Lipopolysaccharides (LPS) are large molecules found in the outer membrane of Gram-negative bacteria, playing a crucial role in the structural integrity of bacterial cells and acting as a potent activator of the immune system. Composed of lipid A, a core oligosaccharide, and an O-antigen polysaccharide, LPS is a critical factor in bacterial pathogenicity. Lipid A is the bioactive component that triggers immune responses by binding to the Toll-like receptor 4 (TLR4) complex on immune cells, leading to the activation of nuclear factor-kappa B (NF-κB) and the release of pro-inflammatory cytokines such as IL-6 and TNF-alpha. While LPS is essential for host defense, its excessive activation can result in septic shock, characterized by systemic inflammation, organ failure, and high mortality. Therapeutic strategies targeting LPS-TLR4 signaling pathways are being explored to manage sepsis and other inflammatory conditions.

Related Products

Human LPS IgG (lipopolysaccharide IgG) ELISA Kit

Ver Producto

Human LPS IgM (lipopolysaccharide IgM) ELISA Kit

Ver Producto

Mouse LPS (Lipopolysaccharides) ELISA Kit

Ver Producto